• Posted: February 25, 2016 Precision Medicine for All

    The Precision Medicine Initiative is a unique scientific endeavor. First, it aims to catalyze progress in precision not just for one disease but across...

    READ MORE
  • Posted: January 28, 2016 Role of FDG-PET/CT in Extramedullary Multiple Myeloma: Correlation of...

    Tirumani SH, Sakellis C, Jacene H, Shinagare AB, Munshi NC, Ramaiya NH, Van den Abbeele AD. Clin Nucl Med. 2016 Jan;41(1):e7-e13. doi:...

    READ MORE
  • Posted: January 28, 2016 Bendamustine, lenalidomide, and dexamethasone (BRD) is highly effective with...

    Kumar SK, Krishnan A, LaPlant B, Laumann K, Roy V, Zimmerman T, Gertz MA, Buadi FK, Stockerl Goldstein K, Birgin A, Fiala M, Duarte L, Maharaj M, Levy J, Vij...

    READ MORE
  • Posted: January 28, 2016 Post-transcriptional Modifications Contribute to the Upregulation of Cyclin D2...

    Misiewicz-Krzeminska I, Sarasquete ME, Vicente-Dueñas C, Krzeminski P, Wiktorska K, Corchete LA, Quwaider D, Rojas EA, Corral R, Martín AA, Escalante F,...

    READ MORE
  • Posted: January 28, 2016 UCHL1 is a biomarker of aggressive multiple myeloma required for disease...

    Hussain S, Bedekovics T, Chesi M, Bergsagel PL, Galardy PJ. Oncotarget. 2015 Dec 1;6(38):40704-18. doi: 10.18632/oncotarget.5727. PMID: 26513019 [PubMed - in...

    READ MORE
  • Posted: January 28, 2016 Serum levels of soluble programmed death ligand 1 predict treatment response...

    Wang L, Wang H, Chen H, Wang WD, Chen XQ, Geng QR, Xia ZJ, Lu Y. Oncotarget. 2015 Dec 1;6(38):41228-36. doi: 10.18632/oncotarget.5682. PMID: 26515600 [PubMed -...

    READ MORE
  • Posted: January 28, 2016 Understanding the role of hyperdiploidy in myeloma prognosis: which trisomies...

    Chretien ML, Corre J, Lauwers-Cances V, Magrangeas F, Cleynen A, Yon E, Hulin C, Leleu X, Orsini-Piocelle F, Blade JS, Sohn C, Karlin L, Delbrel X, Hebraud B,...

    READ MORE
  • Posted: January 28, 2016 Comparison of serum free light chain and urine electrophoresis for the...

    Dejoie T, Attal M, Moreau P, Harousseau JL, Avet-Loiseau H. Haematologica. 2015 Dec 3. pii: haematol.2015.126797. [Epub ahead of print] PMID: 26635032 [PubMed...

    READ MORE
  • Posted: January 28, 2016 FOXM1 is a therapeutic target for high-risk multiple myeloma.

    Gu C, Yang Y, Sompallae R, Xu H, Tompkins VS, Holman C, Hose D, Goldschmidt H, Tricot G, Zhan F, Janz S. Leukemia. 2015 Dec 9. doi: 10.1038/leu.2015.334. [Epub...

    READ MORE
  • Posted: January 28, 2016 Carfilzomib and dexamethasone versus bortezomib and dexamethasone for patients...

    Dimopoulos MA, Moreau P, Palumbo A, Joshua D, Pour L, Hájek R, Facon T, Ludwig H, Oriol A, Goldschmidt H, Rosiñol L, Straub J, Suvorov A, Araujo C,...

    READ MORE

Page 11/15